Biopharma firm Radius Health is going private in an $890m M&A deal

Radius Health, a biopharmaceutical company that has commercialized an osteoporosis drug and is developing new medicines for cancer and rare diseases, has reached an agreement to be acquired by two private equity firms in an $890m deal.

Source